Stay updated on Nivolumab in CNS and Testicular Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in CNS and Testicular Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in CNS and Testicular Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-11T20:21:42.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the earlier Revision: v3.4.1 notice about government funding and operating status.
    Difference
    0.3%
    Check dated 2026-02-11T05:58:30.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide funding status notice was added, informing users that information may not be up to date; the page revision was updated to v3.4.1, replacing the previous v3.4.0 version. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T04:35:02.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI changes include showing the glossary option and small footer text updates such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and a revision note indicating v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T02:49:38.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision history updated: added Revision v3.3.4 and removed Revision v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T01:53:17.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Introduced a consolidated Locations section listing all study sites (US states and international regions) and updated the page revision to v3.3.3; the HHS Vulnerability Disclosure entry was removed.
    Difference
    2%
    Check dated 2025-12-23T17:13:36.000Z thumbnail image

Stay in the know with updates to Nivolumab in CNS and Testicular Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in CNS and Testicular Lymphoma Clinical Trial page.